Cargando…
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a Drosophila model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycol...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557627/ https://www.ncbi.nlm.nih.gov/pubmed/31180318 http://dx.doi.org/10.7554/eLife.45114 |
_version_ | 1783425475771629568 |
---|---|
author | Manzo, Ernesto Lorenzini, Ileana Barrameda, Dianne O'Conner, Abigail G Barrows, Jordan M Starr, Alexander Kovalik, Tina Rabichow, Benjamin E Lehmkuhl, Erik M Shreiner, Dakotah D Joardar, Archi Liévens, Jean-Charles Bowser, Robert Sattler, Rita Zarnescu, Daniela C |
author_facet | Manzo, Ernesto Lorenzini, Ileana Barrameda, Dianne O'Conner, Abigail G Barrows, Jordan M Starr, Alexander Kovalik, Tina Rabichow, Benjamin E Lehmkuhl, Erik M Shreiner, Dakotah D Joardar, Archi Liévens, Jean-Charles Bowser, Robert Sattler, Rita Zarnescu, Daniela C |
author_sort | Manzo, Ernesto |
collection | PubMed |
description | Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a Drosophila model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycolysis may be neuroprotective. Indeed, a high sugar diet improves locomotor and lifespan defects caused by TDP-43 proteinopathy in motor neurons or glia, but not muscle, suggesting that metabolic dysregulation occurs in the nervous system. Overexpressing human glucose transporter GLUT-3 in motor neurons mitigates TDP-43 dependent defects in synaptic vesicle recycling and improves locomotion. Furthermore, PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology. Surprisingly, PFK overexpression rescues TDP-43 induced locomotor deficits. These findings from multiple ALS models show that mechanistically, glycolysis is upregulated in degenerating motor neurons as a compensatory mechanism and suggest that increased glucose availability is protective. |
format | Online Article Text |
id | pubmed-6557627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-65576272019-06-12 Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS Manzo, Ernesto Lorenzini, Ileana Barrameda, Dianne O'Conner, Abigail G Barrows, Jordan M Starr, Alexander Kovalik, Tina Rabichow, Benjamin E Lehmkuhl, Erik M Shreiner, Dakotah D Joardar, Archi Liévens, Jean-Charles Bowser, Robert Sattler, Rita Zarnescu, Daniela C eLife Neuroscience Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a Drosophila model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycolysis may be neuroprotective. Indeed, a high sugar diet improves locomotor and lifespan defects caused by TDP-43 proteinopathy in motor neurons or glia, but not muscle, suggesting that metabolic dysregulation occurs in the nervous system. Overexpressing human glucose transporter GLUT-3 in motor neurons mitigates TDP-43 dependent defects in synaptic vesicle recycling and improves locomotion. Furthermore, PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology. Surprisingly, PFK overexpression rescues TDP-43 induced locomotor deficits. These findings from multiple ALS models show that mechanistically, glycolysis is upregulated in degenerating motor neurons as a compensatory mechanism and suggest that increased glucose availability is protective. eLife Sciences Publications, Ltd 2019-06-10 /pmc/articles/PMC6557627/ /pubmed/31180318 http://dx.doi.org/10.7554/eLife.45114 Text en © 2019, Manzo et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Neuroscience Manzo, Ernesto Lorenzini, Ileana Barrameda, Dianne O'Conner, Abigail G Barrows, Jordan M Starr, Alexander Kovalik, Tina Rabichow, Benjamin E Lehmkuhl, Erik M Shreiner, Dakotah D Joardar, Archi Liévens, Jean-Charles Bowser, Robert Sattler, Rita Zarnescu, Daniela C Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS |
title | Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS |
title_full | Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS |
title_fullStr | Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS |
title_full_unstemmed | Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS |
title_short | Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS |
title_sort | glycolysis upregulation is neuroprotective as a compensatory mechanism in als |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557627/ https://www.ncbi.nlm.nih.gov/pubmed/31180318 http://dx.doi.org/10.7554/eLife.45114 |
work_keys_str_mv | AT manzoernesto glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT lorenziniileana glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT barramedadianne glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT oconnerabigailg glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT barrowsjordanm glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT starralexander glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT kovaliktina glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT rabichowbenjamine glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT lehmkuhlerikm glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT shreinerdakotahd glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT joardararchi glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT lievensjeancharles glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT bowserrobert glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT sattlerrita glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals AT zarnescudanielac glycolysisupregulationisneuroprotectiveasacompensatorymechanisminals |